Zhao M - Search Results

1

Distribution of paclitaxel in plasma and cerebrospinal fluid.

Gelderblom H, Baker SD, Zhao M, Verweij J, Sparreboom A. Gelderblom H, et al. Among authors: zhao m. Anticancer Drugs. 2003 Jun;14(5):365-8. doi: 10.1097/00001813-200306000-00007. Anticancer Drugs. 2003. PMID: 12782943 Clinical Trial.

2

Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography-tandem mass spectrometry.

Sparreboom A, Zhao M, Brahmer JR, Verweij J, Baker SD. Sparreboom A, et al. Among authors: zhao m. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 25;773(2):183-90. doi: 10.1016/s1570-0232(02)00167-8. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12031845

3

Limited cerebrospinal fluid penetration of docetaxel.

ten Tije AJ, Loos WJ, Zhao M, Baker SD, Enting RH, van der Meulen H, Verweij J, Sparreboom A. ten Tije AJ, et al. Among authors: zhao m. Anticancer Drugs. 2004 Aug;15(7):715-8. doi: 10.1097/01.cad.0000136882.19552.8f. Anticancer Drugs. 2004. PMID: 15269603

4

Comparative pharmacokinetics of weekly and every-three-weeks docetaxel.

Baker SD, Zhao M, Lee CK, Verweij J, Zabelina Y, Brahmer JR, Wolff AC, Sparreboom A, Carducci MA. Baker SD, et al. Among authors: zhao m. Clin Cancer Res. 2004 Mar 15;10(6):1976-83. doi: 10.1158/1078-0432.ccr-0842-03. Clin Cancer Res. 2004. PMID: 15041715 Clinical Trial.

5

Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan.

van Erp NP, Baker SD, Zhao M, Rudek MA, Guchelaar HJ, Nortier JW, Sparreboom A, Gelderblom H. van Erp NP, et al. Among authors: zhao m. Clin Cancer Res. 2005 Nov 1;11(21):7800-6. doi: 10.1158/1078-0432.CCR-05-1288. Clin Cancer Res. 2005. PMID: 16278402

6

Influence of CYP3A4 inhibition on the steady-state pharmacokinetics of imatinib.

van Erp NP, Gelderblom H, Karlsson MO, Li J, Zhao M, Ouwerkerk J, Nortier JW, Guchelaar HJ, Baker SD, Sparreboom A. van Erp NP, et al. Among authors: zhao m. Clin Cancer Res. 2007 Dec 15;13(24):7394-400. doi: 10.1158/1078-0432.CCR-07-0346. Clin Cancer Res. 2007. PMID: 18094422 Clinical Trial.

7

Simultaneous analysis of docetaxel and the formulation vehicle polysorbate 80 in human plasma by liquid chromatography/tandem mass spectrometry.

Baker SD, Zhao M, He P, Carducci MA, Verweij J, Sparreboom A. Baker SD, et al. Among authors: zhao m. Anal Biochem. 2004 Jan 15;324(2):276-84. doi: 10.1016/j.ab.2003.09.038. Anal Biochem. 2004. PMID: 14690692

8

Validation and implementation of a method for determination of bryostatin 1 in human plasma by using liquid chromatography/tandem mass spectrometry.

Zhao M, Rudek MA, He P, Smith BD, Baker SD. Zhao M, et al. Anal Biochem. 2005 Feb 1;337(1):143-8. doi: 10.1016/j.ab.2004.10.030. Anal Biochem. 2005. PMID: 15649387

9

CYP3A phenotyping approach to predict systemic exposure to EGFR tyrosine kinase inhibitors.

Li J, Karlsson MO, Brahmer J, Spitz A, Zhao M, Hidalgo M, Baker SD. Li J, et al. Among authors: zhao m. J Natl Cancer Inst. 2006 Dec 6;98(23):1714-23. doi: 10.1093/jnci/djj466. J Natl Cancer Inst. 2006. PMID: 17148773 Clinical Trial.

10

A rapid and sensitive method for determination of dimethyl benzoylphenyl urea in human plasma by using LC/MS/MS.

Zhao M, Zabelina Y, Rudek MA, Wolff AC, Baker SD. Zhao M, et al. J Pharm Biomed Anal. 2003 Nov 24;33(4):725-33. doi: 10.1016/s0731-7085(03)00424-2. J Pharm Biomed Anal. 2003. PMID: 14623599

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,281 results

Search Page

Filters